London, United Kingdom · Founded 2019 · Privately Held (backing)
Developer of a platform designed for pathogen analysis to create antigen and vaccine designs. Baseimmune is based in London, United Kingdom and was founded in 2019. It has raised $16.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$16.8M
Last round
—
Cap table — not yet on record
Baseimmune's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Baseimmune with a free account
·The complete investor list: 15 names
·Watch Baseimmune: the Monday email on marks, rounds and moves
